Skip to main content
. 2020 Jun 25;36(Suppl 1):S9–S17. doi: 10.3904/kjim.2019.279

Figure 2.

Figure 2.

Kaplan-Meier curves show the probability for development of loss of response (LOT) to anti-tumor necrosis factor (TNF) agent for immunomodulator expose group (A), and naïve group (B). Combination therapy is presented with dotted line, monotherapy with solid line.